Cofoe Medical Technology Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100004Y98
CNY
57.22
0.99 (1.76%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
3,370.67
2,976.68
2,842.38
2,966.04
2,265.34
2,360.96
1,462.03
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,370.67
2,976.68
2,842.38
2,966.04
2,265.34
2,360.96
1,462.03
Raw Material Cost
1,717.82
1,557.95
1,721.04
1,872.35
1,328.10
1,365.28
907.48
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
595.97
528.72
0.00
0.00
0.00
0.00
134.78
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
19.30
20.43
15.40
12.96
7.64
2.25
5.10
Selling and Distribution Expenses
1,206.04
982.26
758.51
691.10
434.35
474.93
404.92
Other Expenses
-53.22
-45.86
8.88
9.72
5.95
4.04
-12.44
Total Expenditure (Excl Depreciation)
3,006.96
2,630.73
2,583.70
2,673.58
1,829.57
1,882.83
1,327.85
Operating Profit (PBDIT) excl Other Income
363.7
346
258.7
292.5
435.79999999999995
478.1
134.2
Other Income
72.82
73.28
99.01
127.26
86.79
37.20
28.75
Operating Profit (PBDIT)
600.86
564.25
465.35
502.93
594.27
533.37
158.92
Interest
19.30
20.43
15.40
12.96
7.64
2.25
5.10
Exceptional Items
51.54
12.93
-5.29
-30.68
6.34
0.21
0.23
Gross Profit (PBDT)
1,652.85
1,418.73
1,121.35
1,093.69
937.24
995.68
554.55
Depreciation
208.03
181.25
158.82
124.88
84.33
29.88
8.09
Profit Before Tax
425.06
375.50
285.84
334.41
508.64
501.45
145.96
Tax
55.53
59.66
32.84
32.37
78.74
75.48
21.76
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
371.61
311.75
254.28
301.68
428.86
423.95
123.69
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
371.61
311.75
254.28
301.68
428.86
423.95
123.69
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.29
0.59
-1.41
0.34
0.73
0.59
0.52
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
370.32
312.34
252.87
302.02
429.59
424.54
124.20
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,866.86
4,796.60
4,899.20
5,020.34
4,947.21
991.64
596.47
Earnings per share (EPS)
1.81
1.51
1.24
1.45
2.06
2.04
0.59
Diluted Earnings per share
1.81
1.51
1.24
1.45
2.06
2.04
0.59
Operating Profit Margin (Excl OI)
9.49%
10.4%
7.3%
8.46%
18.68%
19.75%
8.35%
Gross Profit Margin
18.78%
18.7%
15.64%
15.48%
26.18%
22.5%
10.54%
PAT Margin
11.02%
10.47%
8.95%
10.17%
18.93%
17.96%
8.46%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 13.24% vs 4.72% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 18.57% vs 23.49% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 7.54% vs 34.04% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -5.39% vs 32.47% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has fallen from Dec 2024

Compare Annual Results Of Cofoe Medical Technology Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
3,370.67
0
3,370.67
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,370.67
0
3,370.67
Raw Material Cost
1,717.82
0
1,717.82
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
595.97
0
595.97
Power Cost
0
0
0.00
Manufacturing Expenses
19.30
0
19.30
Selling and Distribution Expenses
1,206.04
0
1,206.04
Other Expenses
-53.22
0.00
-53.22
Total Expenditure (Excl Depreciation)
3,006.96
0
3,006.96
Operating Profit (PBDIT) excl Other Income
363.71
0.00
363.71
Other Income
72.82
0
72.82
Operating Profit (PBDIT)
600.86
0
600.86
Interest
19.30
0
19.30
Exceptional Items
51.54
0
51.54
Gross Profit (PBDT)
1,652.85
0
1,652.85
Depreciation
208.03
0
208.03
Profit Before Tax
425.06
0
425.06
Tax
55.53
0
55.53
Provisions and contingencies
0
0
0.00
Profit After Tax
371.61
0
371.61
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
371.61
0
371.61
Share in Profit of Associates
0
0
0.00
Minority Interest
-1.29
0
-1.29
Other related items
0.00
0.00
0.00
Consolidated Net Profit
370.32
0
370.32
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,866.86
0
4,866.86
Earnings per share (EPS)
1.81
0
1.81
Diluted Earnings per share
1.81
0
1.81
Operating Profit Margin (Excl OI)
9.49%
0%
0.00
9.49%
Gross Profit Margin
18.78%
0%
0.00
18.78%
PAT Margin
11.02%
0%
0.00
11.02%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 337.07 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 13.24% vs 4.72% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 37.03 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 18.57% vs 23.49% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 52.80 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 7.54% vs 34.04% in Dec 2024

Annual - Interest
Interest 1.93 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -5.39% vs 32.47% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.49%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has fallen from Dec 2024